Home RxNorm 1085680 triamcinolone diacetate 40 MG/ML Injectable Suspension Drug identity information. FDA.report links public drug records from RxNav, DailyMed, FDA NDC, Drugs@FDA, and related public sources where available. This page is informational only and is not medical, prescribing, or regulatory advice.
RxCUI 1085680
RxNorm name triamcinolone diacetate 40 MG/ML Injectable Suspension
Term type SCD
Status Active
Updated 2026-06-14 07:04:37 RxNorm Status History#
Status Active
Source RXNORM
Current YES
Release start 022011
Active start 022011
Multiple ingredient NO
Branded NO Ingredients And Strength# Ingredient, Strength, Base table Ingredient Strength Base Basis of strength triamcinolone diacetate 40 MG / 1 ML triamcinolone triamcinolone diacetate
Derived Ingredient Concepts# RxNav Current And Historical NDCs# RxNav current and historical NDC rows page 3 of 3 · 254 matching rows.
NDC11, Source, Active table NDC11 Source Active 55553020405 rxnav_historical_indirect 55726020405 rxnav_historical_indirect 57317020201 rxnav_historical_indirect 57317020205 rxnav_historical_indirect 57783029303 rxnav_historical_indirect 57783029304 rxnav_historical_indirect 57783029307 rxnav_historical_indirect 58016979901 rxnav_historical_indirect 58441029307 rxnav_historical_indirect 63252029307 rxnav_historical_indirect 66466980008 rxnav_historical 66466981008 rxnav_historical_indirect 66467980008 rxnav_historical 66467981008 rxnav_historical_indirect
UNII Substances# UNII substance links page 1 of 1 · 0 matching rows.
No records found.
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings# unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 0 matching rows.
No records found.
Recently Linked DailyMed Labels# Set ID, Title, Manufacturer table Set ID Title Manufacturer Effective 3f045347-3e5e-4bbd-90f8-6c3100985ca5 These highlights do not include all the information needed to use TRIESENCE ® (triamcinolone acetonide injectable suspension) 40 mg/mL safely and effectively. See full prescribing information for TRIESENCE ® suspension. TRIESENCE ® (triamcinolone acetonide injectable suspension) 40 mg/mL Initial U.S. Approval: 1957 Alcon Laboratories, Inc. | Alcon Research LLC 20240916 cf970688-cd77-b95c-4bd9-c541590e9722 KENALOG ® -40 INJECTION KENALOG ® -80 INJECTION (triamcinolone acetonide injectable suspension, USP) E.R. Squibb & Sons, L.L.C. 20240820 1186a600-682d-407d-9579-9aba8f9f0a88 Triamcinolone Acetonide Injectable Suspension, USP Sandoz Inc 20181008 1156c8a9-e2c1-49cb-b395-93959820c14f KENALOG ® -40 INJECTION (triamcinolone acetonide injectable suspension, USP) Proficient Rx LP 20140204 d4048a8e-0fe8-4185-b23e-386eb38c2337 National Council for Prescription Drug Programs 20130213 0d61ba7b-8aba-4569-8334-5d24bbf99578 KENALOG ® -40 INJECTION (triamcinolone acetonide injectable suspension, USP) Dispensing Solutions, Inc. 20120914 153f36e3-58f9-4d0a-88d8-aaf3e2593269 National Council for Prescription Drug Programs 20120724 400c3ac9-8635-4cb6-9d8c-b4b13303e9fb National Council for Prescription Drug Programs 20120724 8b6efe30-f13f-4c07-b0d0-80260e9caec6 National Council for Prescription Drug Programs 20120724 b78e952b-4a4f-4dbb-ac97-bf155b97b10e National Council for Prescription Drug Programs 20120724 b854e809-27b7-4afc-9b15-88f02ad6b1a6 National Council for Prescription Drug Programs 20120724 c97ffb6b-a47c-4d7a-a126-321cd7db83c5 National Council for Prescription Drug Programs 20120724 cc7f114f-5ccf-44aa-a58a-964d4816445d National Council for Prescription Drug Programs 20120724 d53c1531-3864-4d07-8af2-31f7b5529d5c KENALOG ® -40 INJECTION triamcinolone acetonide injectable suspension, USP Physicians Total Care, Inc. 20101101
Drug Classes# Source, Class ID, Class table Source Class ID Class Type Relationship Drug concept ATC C05AA Corticosteroids ATC1-4 triamcinolone ATC R01AD Corticosteroids ATC1-4 triamcinolone ATC A01AC Corticosteroids for local oral treatment ATC1-4 triamcinolone ATC D07AB Corticosteroids, moderately potent (group II) ATC1-4 triamcinolone ATC D07XB Corticosteroids, moderately potent, other combinations ATC1-4 triamcinolone ATC S01BA Corticosteroids, plain ATC1-4 triamcinolone ATC R03BA Glucocorticoids ATC1-4 triamcinolone ATC H02AB Glucocorticoids ATC1-4 triamcinolone FDASPL N0000175576 Corticosteroid EPC has_epc triamcinolone FDASPL N0000175450 Corticosteroid Hormone Receptor Agonists MOA has_moa triamcinolone MEDRT D014221 Triamcinolone CHEM has_ingredient triamcinolone MEDRT D014221 Triamcinolone CHEM has_ingredient triamcinolone diacetate MEDRT D000309 Adrenal Insufficiency DISEASE may_treat triamcinolone diacetate MEDRT D000309 Adrenal Insufficiency DISEASE may_treat triamcinolone MEDRT D000743 Anemia, Hemolytic DISEASE may_treat triamcinolone diacetate MEDRT D000743 Anemia, Hemolytic DISEASE may_treat triamcinolone MEDRT D015210 Arthritis, Gouty DISEASE may_prevent triamcinolone MEDRT D015210 Arthritis, Gouty DISEASE may_prevent triamcinolone diacetate MEDRT D001172 Arthritis, Rheumatoid DISEASE may_prevent triamcinolone MEDRT D001172 Arthritis, Rheumatoid DISEASE may_prevent triamcinolone diacetate MEDRT D001249 Asthma DISEASE may_prevent triamcinolone MEDRT D001249 Asthma DISEASE may_prevent triamcinolone diacetate MEDRT D001607 Berylliosis DISEASE may_treat triamcinolone diacetate MEDRT D001607 Berylliosis DISEASE may_treat triamcinolone MEDRT D001986 Bronchial Spasm DISEASE may_treat triamcinolone MEDRT D001986 Bronchial Spasm DISEASE may_treat triamcinolone diacetate MEDRT D003093 Colitis, Ulcerative DISEASE may_treat triamcinolone MEDRT D003093 Colitis, Ulcerative DISEASE may_treat triamcinolone diacetate MEDRT D003874 Dermatitis Herpetiformis DISEASE may_treat triamcinolone MEDRT D003874 Dermatitis Herpetiformis DISEASE may_treat triamcinolone diacetate MEDRT D003876 Dermatitis, Atopic DISEASE may_treat triamcinolone diacetate MEDRT D003876 Dermatitis, Atopic DISEASE may_treat triamcinolone MEDRT D004342 Drug Hypersensitivity DISEASE ci_with triamcinolone diacetate MEDRT D004342 Drug Hypersensitivity DISEASE ci_with triamcinolone MEDRT D004892 Erythema Multiforme DISEASE may_treat triamcinolone MEDRT D004892 Erythema Multiforme DISEASE may_treat triamcinolone diacetate MEDRT D005148 Facial Dermatoses DISEASE may_treat triamcinolone MEDRT D005148 Facial Dermatoses DISEASE may_treat triamcinolone diacetate MEDRT D005533 Foot Dermatoses DISEASE may_treat triamcinolone diacetate MEDRT D005533 Foot Dermatoses DISEASE may_treat triamcinolone MEDRT D006229 Hand Dermatoses DISEASE may_treat triamcinolone MEDRT D006229 Hand Dermatoses DISEASE may_treat triamcinolone diacetate MEDRT D006934 Hypercalcemia DISEASE may_treat triamcinolone diacetate MEDRT D006934 Hypercalcemia DISEASE may_treat triamcinolone MEDRT D007239 Infections DISEASE ci_with triamcinolone diacetate MEDRT D007239 Infections DISEASE ci_with triamcinolone MEDRT D007249 Inflammation DISEASE may_treat triamcinolone diacetate MEDRT D007249 Inflammation DISEASE may_treat triamcinolone MEDRT D007868 Leg Dermatoses DISEASE may_treat triamcinolone diacetate MEDRT D007868 Leg Dermatoses DISEASE may_treat triamcinolone MEDRT D008180 Lupus Erythematosus, Systemic DISEASE may_treat triamcinolone diacetate MEDRT D008180 Lupus Erythematosus, Systemic DISEASE may_treat triamcinolone MEDRT D009103 Multiple Sclerosis DISEASE may_treat triamcinolone MEDRT D009103 Multiple Sclerosis DISEASE may_treat triamcinolone diacetate MEDRT D009181 Mycoses DISEASE ci_with triamcinolone MEDRT D009181 Mycoses DISEASE ci_with triamcinolone diacetate MEDRT D009404 Nephrotic Syndrome DISEASE may_treat triamcinolone diacetate MEDRT D009404 Nephrotic Syndrome DISEASE may_treat triamcinolone MEDRT D010392 Pemphigus DISEASE may_treat triamcinolone MEDRT D010392 Pemphigus DISEASE may_treat triamcinolone diacetate MEDRT D012216 Rheumatic Diseases DISEASE may_treat triamcinolone diacetate MEDRT D012216 Rheumatic Diseases DISEASE may_treat triamcinolone MEDRT D012221 Rhinitis, Allergic, Perennial DISEASE may_treat triamcinolone MEDRT D012221 Rhinitis, Allergic, Perennial DISEASE may_treat triamcinolone diacetate MEDRT D012536 Scalp Dermatoses DISEASE may_treat triamcinolone diacetate MEDRT D012536 Scalp Dermatoses DISEASE may_treat triamcinolone MEDRT D012713 Serum Sickness DISEASE may_treat triamcinolone MEDRT D012713 Serum Sickness DISEASE may_treat triamcinolone diacetate MEDRT D013167 Spondylitis, Ankylosing DISEASE may_treat triamcinolone diacetate MEDRT D013167 Spondylitis, Ankylosing DISEASE may_treat triamcinolone MEDRT D013224 Status Asthmaticus DISEASE ci_with triamcinolone MEDRT D013224 Status Asthmaticus DISEASE ci_with triamcinolone diacetate MEDRT D013585 Synovitis DISEASE may_treat triamcinolone diacetate MEDRT D013585 Synovitis DISEASE may_treat triamcinolone MEDRT D013966 Thyroiditis DISEASE may_treat triamcinolone MEDRT D013966 Thyroiditis DISEASE may_treat triamcinolone diacetate MEDRT D014397 Tuberculosis, Pulmonary DISEASE may_treat triamcinolone diacetate MEDRT D014397 Tuberculosis, Pulmonary DISEASE may_treat triamcinolone MEDRT D014605 Uveitis DISEASE may_treat triamcinolone MEDRT D014605 Uveitis DISEASE may_treat triamcinolone diacetate MEDRT N0000000159 Glucocorticoid Receptor Agonists MOA has_moa triamcinolone diacetate MEDRT N0000000159 Glucocorticoid Receptor Agonists MOA has_moa triamcinolone MEDRT N0000000134 Lipoxygenase Inhibitors MOA has_moa triamcinolone MEDRT N0000000134 Lipoxygenase Inhibitors MOA has_moa triamcinolone diacetate MEDRT N0000008327 Carbohydrate Metabolism Alteration PE has_pe triamcinolone diacetate MEDRT N0000008327 Carbohydrate Metabolism Alteration PE has_pe triamcinolone MEDRT N0000010253 Decreased Capillary Permeability PE has_pe triamcinolone MEDRT N0000010253 Decreased Capillary Permeability PE has_pe triamcinolone diacetate MEDRT N0000008571 Decreased Cytokine Activity PE has_pe triamcinolone diacetate MEDRT N0000008571 Decreased Cytokine Activity PE has_pe triamcinolone MEDRT N0000010248 Decreased Fibroblast Migration PE has_pe triamcinolone MEDRT N0000010248 Decreased Fibroblast Migration PE has_pe triamcinolone diacetate MEDRT N0000008645 Decreased Glucocorticoid Secretion PE has_pe triamcinolone diacetate MEDRT N0000008645 Decreased Glucocorticoid Secretion PE has_pe triamcinolone MEDRT N0000008681 Decreased Leukotriene Activity PE has_pe triamcinolone MEDRT N0000008681 Decreased Leukotriene Activity PE has_pe triamcinolone diacetate MEDRT N0000010246 Decreased Polymorphonuclear Leukocyte Migration PE has_pe triamcinolone diacetate MEDRT N0000010246 Decreased Polymorphonuclear Leukocyte Migration PE has_pe triamcinolone MEDRT N0000008834 Decreased Prostaglandin Activity PE has_pe triamcinolone MEDRT N0000008834 Decreased Prostaglandin Activity PE has_pe triamcinolone diacetate MEDRT N0000008841 Decreased Protein Synthesis PE has_pe triamcinolone diacetate MEDRT N0000008841 Decreased Protein Synthesis PE has_pe triamcinolone MEDRT N0000009004 Decreased Thromboxane Activity PE has_pe triamcinolone MEDRT N0000009004 Decreased Thromboxane Activity PE has_pe triamcinolone diacetate MEDRT N0000009739 Lipid Metabolism Alteration PE has_pe triamcinolone diacetate MEDRT N0000009739 Lipid Metabolism Alteration PE has_pe triamcinolone MEDRT N0000009741 Lysosomal Function Alteration PE has_pe triamcinolone MEDRT N0000009741 Lysosomal Function Alteration PE has_pe triamcinolone diacetate
Properties# Category, Property, Value table Category Property Value ATTRIBUTES GENERAL_CARDINALITY SINGLE CODES SNOMEDCT 375176003 CODES VUID 4001619 SOURCES Source US Edition of SNOMED_CT